Liquichek™ Qualitative Urine Toxicology Control, Negative Level
Manufacturer: Supplier Page
SKU: 454
Description
Bio-Rad's Liquichek Qualitative Urine Toxicology Control, Negative Level, is an assayed, liquid-based quality control material formulated with a human urine matrix. It is intended for use in monitoring the precision and consistency of qualitative toxicology screening assays. This negative control is designed to produce non-reactive results for a comprehensive panel of analytes, including d-Amphetamine, d-Methamphetamine, MDMA, Secobarbital, Benzodiazepines (Nordiazepam, Oxazepam), the THC metabolite 11-Nor-?-9-THC-9-COOH, Benzoylecgonine, Ethanol, LSD, Methadone, Methaqualone, free Morphine, Oxycodone, PCP, Propoxyphene, and Nortriptyline. The product is supplied as a pack of six 3 mL vials, catalog number 454. It is characterized as cross-platform compatible, allowing for use with various analytical instruments and methodologies commonly employed in clinical toxicology laboratories.
Specifications
| Item | Liquichek™ Qualitative Urine Toxicology Control, Negative Level |
| Company | Bio-Rad Laboratories |
| Price | Supplier PageView Company Product Page |
| Catalog Number | 454 |
| Quantity | EA |
| Size(s) | 6 x 3 mL |
| Analytes | d-Amphetamine, d-Methamphetamine, 3, 4-Methylenedioxymethamphetamine (MDMA), Secobarbital, Benzodiazepines, Nordiazepam, Oxazepam, 11-Nor-?-9-THC-9-COOH, Benzoylecgonine, Ethanol (mg/dL), Lysergic Acid Diethylamide (LSD), Methadone, Methaqualone, Morphine (Free), Oxycodone, Phencyclidine (PCP), Propoxyphene, Nortriptyline |
| Required Equipment | Cross-platform compatible |
| Stability | 3 year shelf life at 2–8°C |
| Format | Liquid |